0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Viewpoint |

Transgender Patients, Isotretinoin, and US Food and Drug Administration–Mandated Risk Evaluation and Mitigation Strategies A Prescription for Inclusion

Kenneth A. Katz, MD, MSc, MSCE1
[+] Author Affiliations
1Department of Dermatology, Kaiser Permanente, Pleasanton, California
JAMA Dermatol. 2016;152(5):513-514. doi:10.1001/jamadermatol.2015.5547.
Text Size: A A A
Published online

Extract

This Viewpoint discusses initiatives to improve health care for transgender persons, including gender-neutral practice that would help ensure their access to important medications.

Caitlyn Jenner has vaulted to celebrity status, Facebook has expanded its gender nomenclature, and the Pentagon has announced plans to permit transgender service members to serve openly. Although recent news about transgender persons is not uniformly rosy—transgender persons in the United States and elsewhere are still targets of violent, sometimes lethal attacks, and voters in Houston, Texas, recently repealed that city’s Equal Rights Ordinance—transgender visibility and equality have made remarkable advances. Those advances have paralleled strides made in scientific understanding of gender, including replacement of the term gender identity disorder with gender dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition in 2013.

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

526 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();